PPD (PPD) Aktie Kurs

PPD Inc is primarily active in the pharmaceutical and biotechnology industries.

The main competitors of PPD Inc in the market include QuintilesIMS, LabCorp, Icon, and Covance.

PPD Inc is a leading global contract research organization (CRO) specializing in drug development, laboratory services, and clinical trial management. Founded in 1985, PPD has a rich history and a strong background in providing innovative solutions to the pharmaceutical, biotechnology, and medical device industries. The company offers a comprehensive range of services, including early development, clinical research, laboratory services, and post-approval studies. PPD Inc has established itself as a trusted partner for the life sciences industry, delivering high-quality results, efficiency, and expertise in advancing healthcare solutions. With a global presence and a team of experienced professionals, PPD continues to be at the forefront of advancing clinical research and improving patient outcomes.

PPD Inc has achieved significant milestones throughout its history. Some noteworthy achievements include successfully conducting over 230,000 clinical trials, establishing a global presence in more than 46 countries, and consistently delivering innovative solutions to the life sciences industry. The company has also been recognized for its exceptional expertise in clinical research, data management, and regulatory affairs. PPD Inc's commitment to quality and customer satisfaction has enabled it to be a reliable partner for pharmaceutical, biotechnology, and medical device companies worldwide. With its strong track record and industry leadership, PPD Inc continues to make significant strides in advancing healthcare and improving patient outcomes.

PPD Inc primarily operates in over 50 countries and regions worldwide. With a strong global presence, the company offers its comprehensive range of clinical research and laboratory services to clients across various industries. PPD Inc's key markets include the United States, Europe, Asia Pacific, and Latin America. The company's extensive network and expertise allow it to effectively serve clients on a global scale, helping them navigate the complexities of drug development and deliver innovative solutions. PPD Inc's commitment to expanding its presence in emerging markets reinforces its position as a leading provider of life sciences services worldwide.

PPD Inc represents a strong set of values and a clear corporate philosophy. The company focuses on delivering exceptional customer service, fostering a culture of innovation, and maintaining the highest standards of integrity. PPD Inc aims to provide reliable and efficient solutions in the fields of healthcare and clinical research. With its commitment to excellence, PPD Inc strives to deliver value to its clients and contribute to better patient outcomes. The company's dedication to these principles has established it as a trusted leader in the industry, making PPD Inc a go-to choice for businesses and individuals seeking reliable healthcare and clinical research services.

Omregnet til den aktuelle valutakurs handles PPD-aktien til 42,07 EUR (47,28 USD).

PPD-aktien (PPD) er noteret på 1 børser, herunder: NASDAQ (PPD).

PPD Inc is an international pharmaceutical company headquartered in the USA with branches in Europe, Asia, Africa, and Australia. The company operates in the areas of clinical research, pharmacovigilance, laboratory services, and consulting, offering comprehensive solutions to its clients for the development, approval, and monitoring of drugs and medical devices. One of PPD's main divisions is clinical research. The company works closely with pharmaceutical and biotechnology companies, as well as academic research institutions, to conduct clinical trials. PPD provides all the necessary services for conducting a clinical trial, from study design to subject recruitment, data analysis, and reporting. PPD has extensive experience in all phases of clinical research, from Phase I to Phase IV, and has successfully brought numerous drugs to market in the past. Another important division of PPD is pharmacovigilance. Here, the company collects and analyzes data on adverse drug reactions and provides recommendations for risk minimization. PPD works closely with regulatory authorities worldwide to ensure that all data on adverse drug reactions are accurately recorded and analyzed. In addition, PPD offers laboratory services. The company's portfolio includes a wide range of laboratory tests, including bioanalytical tests and safety tests. PPD has extensive expertise in analyzing biological samples, including blood, urine, saliva, and stool samples. The company specializes in identifying molecular markers that are important for disease diagnosis or monitoring therapy success. PPD also offers comprehensive consulting services. Here, the company supports its clients in the development of new therapies and drugs and provides recommendations for optimizing study design and methods. PPD has extensive experience in working with the FDA and other regulatory authorities worldwide, developing strategies for risk minimization and compliance with regulatory requirements. PPD offers a wide range of products and services specifically tailored to the needs of pharmaceutical and biotechnology companies. The company is committed to offering innovative solutions to its clients to accelerate the development of new drugs and therapies. To this end, PPD has made significant investments in its research and development activities in recent years and works closely with customers and partners to develop new and innovative treatment options. Overall, PPD's business model is oriented towards the needs of the pharmaceutical and biotechnology industry. The company offers comprehensive solutions to its clients for the development, approval, and monitoring of drugs and medical devices. PPD is a key partner for innovation in drug development and has successfully brought numerous therapies and drugs to market in the past.

Omsætningen kan for øjeblikket ikke beregnes for PPD.

Overskuddet kan for øjeblikket ikke beregnes for PPD.

P/E-forholdet kan ikke beregnes for PPD i øjeblikket.

P/S-forholdet kan ikke beregnes for PPD i øjeblikket.

AlleAktien-kvalitetsscore for PPD er 4/10.

ISIN for PPD er US69355F1021. ISIN (International Securities Identification Number) er en globalt unik identifikator for værdipapirer.

WKN for PPD er A2PX5V. WKN (Wertpapierkennnummer) er et seks-cifret tysk identifikationsnummer for værdipapirer.

Tickeren for PPD er PPD. Tickersymbolet bruges til at handle PPD-aktier på børsen.